MENU
KNSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kiniksa Pharmaceuticals International (KNSA) Ownership - Who owns Kiniksa Pharmaceuticals International?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.49B
P/E Ratio
164.54
Total Cash
223.78M
Projected Growth
N/A
Total Debt
10.6M
Revenue
384.1M
Risk (Beta)
0.24
Dividend Yield
N/A
Total Cash/Share
3.10
Total Debt/Equity
N/A
Revenue/Share
5.28 USD as % of share price
Fundamentals
KNSA
Capitalization
1.49B
P/E Ratio
164.54
Risk (Beta)
0.24
Dividend Yield
N/A
Total Cash
224M
Total Cash/Share
3.10
Total Debt
10.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.28%
Revenue
384M
ROE
N/A
Book Value
437M
P/B Ratio
3.40
Cash Flow
N/A
Earnings
-0.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
20K
Current Ratio
3.24
Current Revenue Per Employee
377824.90
Dividends Per Share - Security
N/A
EBITDA
-24.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
55.96
Revenue To Assets
-1.75
Shares Held By Institutions
1.58B
Shares Outstanding - Current
72.2M
Total Liabilities
118M
Total Volume MTD
N/A
Value
-1
Gain YTD
17.389
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com